Top

Published in:

Open Access 01-12-2024 | Analysis

Importance of LINC00852/miR-145-5p in breast cancer: a bioinformatics and experimental study

Authors: Abbas Shakoori, Asghar Hosseinzadeh, Nahid Nafisi, Ramesh Omranipour, Leyla Sahebi, Nazanin Hosseinkhan, Mohsen Ahmadi, Soudeh Ghafouri-Fard, Maryam Abtin

Published in: Discover Oncology | Issue 1/2024

Abstract

Purpose

We aimed to examine the importance of an lncRNA, namely LINC00852, in the pathogenesis of breast cancer.

Materials and methods

In the current study, we used several online tools to examine the importance of LINC00852 in breast cancer. Then, we examined these findings in 50 pairs of breast cancer tissues and adjacent non-cancerous ones. We also re-evaluated the data of miR-145-5p signature from our recent study.

Results

While in silico tools revealed down-regulation of LINC00852 in breast cancer samples, expression assays showed significant up-regulation of this lncRNAs in breast cancer samples compared with matching control samples from Iranian patients. miR-145-5p was under-expressed in breast cancer samples compared with non-cancerous samples. LINC00852 could separate breast cancer tissues from adjacent non-malignant tissues with an AUC value of 0.7218 (P value < 0.001).

Conclusion

The current study potentiates LINC00852/miR-145-5p axis as a possible contributor to the pathogenesis of breast cancer.

Zhang Y, et al. LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer. Mol Cancer. 2023;22(1):41.PubMedPubMedCentralCrossRef

Lei C, et al. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway. Cancer Biol Ther. 2022;23(1):1–13.PubMedPubMedCentralCrossRef

Li M, et al. Application value of circulating LncRNA in diagnosis, treatment, and prognosis of breast cancer. Funct Integr Genomics. 2023;23(1):61.PubMedCrossRef

Liu S, et al. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties. J Hematol Oncol. 2021;14(1):178.PubMedPubMedCentralCrossRef

Chen F, et al. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer. J Clin Lab Anal. 2022;36(4): e24302.PubMedPubMedCentralCrossRef

Zong S, et al. LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis. Aging (Albany NY). 2021;13(19):23169–81.PubMedCrossRef

Chen X, et al. Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer. Nat Commun. 2022;13(1):7160.PubMedPubMedCentralCrossRef

Li X, et al. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer. J Transl Med. 2020;18(1):331.PubMedPubMedCentralCrossRef

Müller V, et al. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Mol Oncol. 2019;13(5):1137–49.PubMedPubMedCentralCrossRef

10.

Yin X, et al. Identification of key modules and genes associated with breast cancer prognosis using WGCNA and ceRNA network analysis. Aging (Albany NY). 2020;13(2):2519–38.PubMedCrossRef

11.

Yue X, et al. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. Biomed J. 2021;44(6 Suppl 2):S296-s304.PubMedCrossRef

12.

Ouyang J, et al. LncRNA PRNCR1 Promotes Breast Cancer Proliferation and Inhibits Apoptosis by Modulating microRNA-377/CCND2/MEK/MAPK Axis. Arch Med Res. 2021;52(5):471–82.PubMedCrossRef

13.

Kong X, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105–17.PubMedCrossRef

14.

Zhang D, Ding X, Peng M. LncRNA SNHG14 accelerates breast cancer progression through sponging miR-543 and regulating KLF7 expression. Arch Gynecol Obstet. 2022;305(6):1507–16.PubMedCrossRef

15.

Dwivedi S, et al. Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis. Indian J Clin Biochem. 2019;34(1):3–18.PubMedPubMedCentralCrossRef

16.

Dwivedi S, Purohit P, Sharma P. Single Cell Omics Approach: A Paradigm Shift in Diagnosis and Therapy of Cancer. Indian J Clin Biochem. 2019;34(1):1–2.PubMedPubMedCentralCrossRef

17.

Dwivedi S, et al. Application of single-cell omics in breast cancer. In: Single-cell omics. Elsevier; 2019. p. 69–103.CrossRef

18.

Liu P, et al. LINC00852 Promotes Lung Adenocarcinoma Spinal Metastasis by Targeting S100A9. J Cancer. 2018;9(22):4139–49.PubMedPubMedCentralCrossRef

19.

Qiao ZW, et al. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression. BMC Cancer. 2021;21(1):1004.PubMedPubMedCentralCrossRef

20.

Chen S. LINC00852 Regulates Cell Proliferation, Invasion, Migration and Apoptosis in Hepatocellular Carcinoma Via the miR-625/E2F1 Axis. Cell Mol Bioeng. 2022;15(2):207–17.PubMedCrossRef

21.

Zhang H, et al. The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell. BMC Cancer. 2022;22(1):1269.PubMedPubMedCentralCrossRef

22.

Cao S, et al. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p. Cell Biol Toxicol. 2023;39(2):483–96.PubMedCrossRef

23.

Li Q, et al. Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma. Cancer Med. 2020;9(17):6354–66.PubMedPubMedCentralCrossRef

24.

Jin L, et al. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Hum Genomics. 2020;14(1):24.PubMedPubMedCentralCrossRef

25.

Tuo Z, Liang L, Zhou R. LINC00852 is associated with poor prognosis in non-small cell lung cancer patients and its inhibition suppresses cancer cell proliferation and chemoresistance via the hsa-miR-145-5p/KLF4 axis. J Gene Med. 2021;23(12): e3384.PubMedCrossRef

26.

Wang J, et al. KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis. Cancer Cell Int. 2019;19:325.PubMedPubMedCentralCrossRef

27.

Teng F, et al. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol Oncol. 2021;15(4):1234–55.PubMedPubMedCentralCrossRef

28.

Ding B, et al. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer. Aging (Albany NY). 2020;12(6):5259–79.PubMedCrossRef

29.

Tang W, et al. miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2. J Surg Res. 2019;236:278–87.PubMedCrossRef

30.

Qu H, et al. LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p. Genes Genomics. 2023;45(5):581–92.PubMedPubMedCentralCrossRef

31.

Dong M, et al. LINC00052 promotes breast cancer cell progression and metastasis by sponging miR-145-5p to modulate TGFBR2 expression. Oncol Lett. 2021;21(5):368.PubMedPubMedCentralCrossRef

32.

Abtin M, et al. Inhibition of breast cancer cell growth and migration through siRNA-mediated modulation of circ_0009910/miR-145-5p/MUC1 axis. Noncoding RNA Res. 2024;9(2):367–75.PubMedPubMedCentralCrossRef

33.

Park S-J, et al. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics. 2019;12:1–8.CrossRef

34.

Jézéquel, P., et al., bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database, 2021. 2021: p. baab007.

35.

Li, J.H., et al., starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res, 2014. 42(Database issue): p. D92–7.

36.

Su Z-D, et al. iLoc-lncRNA: predict the subcellular location of lncRNAs by incorporating octamer composition into general PseKNC. Bioinformatics. 2018;34(24):4196–204.PubMedCrossRef

37.

Liu C-J, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Briefings in Bioinformatics. 2022. https://doi.org/10.1093/bib/bbac558.CrossRefPubMedPubMedCentral

38.

Orsini A, Diquigiovanni C, Bonora E. Omics Technologies Improving Breast Cancer Research and Diagnostics. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms241612690.CrossRefPubMedPubMedCentral

39.

Győrffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101–9.PubMedPubMedCentralCrossRef

40.

Zhang SC, et al. Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer. J Cancer. 2019;10(24):6175–84.PubMedPubMedCentralCrossRef

41.

Qian D, et al. Integrated analysis of ceRNA network reveals prognostic and metastasis associated biomarkers in breast cancer. Front Oncol. 2021;11: 670138.PubMedPubMedCentralCrossRef

42.

Liu Z-Q, et al. Construction and comparison of ceRNA regulatory network for different age female breast cancer. Front Genet. 2021;12: 603544.PubMedPubMedCentralCrossRef

43.

Qi X, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–8.PubMedCrossRef

44.

Hao S, et al. LINC00852 participates in the phycocyanin-mediated restrained vitality of non-small cell lung cancer cells via miR-29a-3p/LAMTOR1 axis. Journal of Functional Foods. 2023;106: 105588.CrossRef

45.

Bahreini F, et al. Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer. Mol Biol Rep. 2021;48(4):3541–7.PubMedCrossRef

46.

Yu L, et al. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med. 2018;22(12):6134–47.PubMedPubMedCentralCrossRef

47.

Ashirbekov Y, et al. Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection. PeerJ. 2020;8: e10494.PubMedPubMedCentralCrossRef

Title: Importance of LINC00852/miR-145-5p in breast cancer: a bioinformatics and experimental study
Authors: Abbas Shakoori
Asghar Hosseinzadeh
Nahid Nafisi
Ramesh Omranipour
Leyla Sahebi
Nazanin Hosseinkhan
Mohsen Ahmadi
Soudeh Ghafouri-Fard
Maryam Abtin
Publication date: 01-12-2024
Publisher: Springer US
Published in: Discover Oncology / Issue 1/2024
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI: https://doi.org/10.1007/s12672-024-01553-5

Insights into the prognostic value and immunological role of CD74 in pan-cancer

Open Access
Thymoma
Research

Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experiments

Open Access
Prostate Cancer
Research

Delineating the role of nuclear receptors in colorectal cancer, a focused review

Open Access
Colorectal Cancer
Review

circPDK1 competitively binds miR-4731-5p to mediate GIGYF1 expression and increase paclitaxel sensitivity in non-small cell lung cancer

Open Access
NSCLC
Research

SPECC1 as a pan-cancer biomarker: unraveling its role in drug sensitivity and resistance mechanisms

Open Access
Analysis

Changes in the tumor microenvironment in recurrent head and neck squamous cell carcinoma and its implication on efficacy of immune checkpoint inhibitors

Open Access
Checkpoint Inhibitors
Research

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content